Abstract.-Twenty-four different glycoproteins were investigated for their ability to inhibit hemagglutination by the A/PR8 and the B/Md influenza virus strains. A relationship between activity, the molecular size, and sialic acid content was found. This relationship was readily shown for the A/PR8 virus if the properties of the glycoproteins were compared with one another on a per cent basis. A proportion of approximately 1: 1:1 for activity (weight basis) to moles sialic acid content to molecular weight existed for each inhibitory glycoprotein with more than 3 per cent sialic acid, on comparison with any other active glycoprotein.
A 1:3 correspondence between viral subunit and sialic acid residues of the inhibitor ovine submaxillary mucin was found experimentally and confirmed by calculation on a molecular model. The most potent inhibitors were the antigens of the human blood-group MN system and the Tamm-Horsfall urinary glycoprotein.
The first direct evidence for the existence of cell receptors for influenza viruses was the observation that they agglutinate erythrocytes." 2 Studies on the nature of influenza virus receptor substances, however, were first confined to the cell-receptor analogues found in body secretions. The potency of these analogues, which have been shown to be glycoproteins, is measured by their ability to inhibit hemagglutination by indicator influenza viruses (cf. ref. 3 ).
More recently a close relation between the M and N antigens of the second human blood-group system and the influenza virus receptors of human erythrocytes has been demonstrated. The activities of both are destroyed concomitantly by influenza viruses.4 Influenza virus receptor glycoproteins possessing blood-group M and N specificity have been isolated from human erythrocyte stroma.-8 Sialic acid in terminal linkage has been implicated as the virus receptor site3 and as the structure involved predominantly in blood-group M and N activity.4 Influenza virus inhibitory activity of different glycoproteins could not be correlated with the quantity of sialic acid present nor with their molecular weight,9' 10 except that the proteolytic cleavage of some inhibitors led to a considerable reduction of their activity.3' "
In the present report, inhibitory activities of the erythrocyte receptors towards two influenza virus strains were compared with each other and with those of inhibitors from other sources in order to define more fully the receptor which is truly complementary to these viruses. Striking relationships were found between antiviral activity, molecular size, and sialic acid content. Results.-Blood-group MM antigen Ca 979, the urinary glycoprotein, the Lea substance, and the meconium glycoprotein were among the six most active inhibitors towards both viruses (Table 1) .
Studies with the A/PR8 virus: Only the AIM antigen Ca 979 and the urinary glycoprotein had similarly high activities; of the eight other glycoproteins with molecular weights >200,000, six showed activities, expressed on a weight basis, of between 1.5 and 7.5 per cent that of Ca 979. The Lea substance and BSM had the highest and equal activities among these six glycoproteins, although the former had only about one tenth of the molecular weight and two thirds of the sialic acid content of the latter. Gamma-A globulin had only a trace of activity, and a2-macroglobulin was inactive. OSA1i, the inhibitor with the highest sialic acid content (weight basis), had comparatively low activity; its activity was only twice that of -y-M globulin, the glycoprotein with one of the smallest amounts of sialic acid (weight basis) of all substances tested. Activity generally depended on the molecular size, since all active glycoproteins with a molecular weight of <200,000 were of low potency, and the number of inactive compounds increased with decreasing molecular size. Expression of the activities of the inhibitors on a molar rather than a weight basis (Table  1 , col. 6) underscored the high potency of Ca 979 and the urinary glyco-protein.
Quantitative comparison of the molecular weights and the number of sialic acid residues of the various glycoproteins was facilitated by expressing these properties for a given glycoprotein as per cent, on a molar basis, of the reference substance Ca 979. Such a comparison is shown in the second and third columns of Table 2 . There was a remarkable parallelism between these two properties for all glycoproteins containing >3 percent sialic acid; if the percentage of molecular weight of a glycoprotein was divided by the per cent value of its sialic acid residues, a ratio approximating 1 was obtained for all glycoproteins, with maximal deviations up to a factor of 3. There was also a relation of these two parameters to activity which became most readily evident if a glycoprotein's activity was expressed on the basis of weight per cent of Ca 979. Table 2 depicts the relations of these properties to one another in the form of ratios for all the active substances with >3 per cent sialic acid. The calculated ratio of molecular weight to activity was very close to 1 for 10 of the 12 glycoproteins listed, that is, the decrease in activity was found to be proportional to the decrease in molecular size. The ratios of mole per cent sialic acid to weight per cent activity of the various glycoproteins also approached 1. They exceeded 3 only for the submaxillary mucins, for which no measured molecular weight was available and for which the figures given represent the mean of all possible molecular weights in the literature. If the lowest molecular weight possible for both substances, 500,000, was chosen instead, then the ratios approached 1 much more closely ( Table 2 ). The mean ratio of mole per cent sialic acid over weight per cent activity for all substances compared in Table 2 was 1.6, as was also the ratio of per cent molecular weight over weight per cent activity for all substances. When the lower molecular weights for the submaxillary mucins were taken, the respective average ratios for all glycoproteins were 1.2 and 1.4.
If the activities of the inhibitors were expressed on a molar basis, as were the other properties, then a decrease of molecular size and sialic acid content in the order of one decadic logarithm was accompanied by a decline in the potency of the active substances by two decadic logarithms, that is, the activity decline proceeded approximately with the square of the decrease of molecular weight and sialic acid content. It follows that one can predict the degree of activity of a glycoprotein whose molecular weight and sialic acid content are known, and that reciprocal approximations can be made from the extent of the hemagglutination inhibition, provided that certain structural conditions are met by the glycoproteins (see Discussion). Thus, in spite of the appropriate size and sialic acid content, five substances listed in Table 1 containing >3 per cent sialic acid had no significant activity with A/PR8 virus. Remarkably, these five glycoproteins were active with the B/Nid influenza virus. Studies with the B/Md viru8: All glycoproteins were more active with the B/Md virus, in relation to Ca 979, than with the A/PR8 virus. They had higher activity also on an absolute basis except for BSM and a1-antitrypsin #166 both of which were slightly more active with the A/PR8 virus. Also, with the B/Md virus the urinary glycoprotein and the Lea substance were more active on a weight basis than was the reference compound. Meconium-Vg antigen was as active as Ca 979, although it had only 4.3 per cent of the molecular weight of the latter. Table 1 shows that all nine glycoproteins having a molecular weight of >60,000 and a sialic acid content of >3.5 per cent were highly active. Except for fetuin, which was much more potent, the activities of substances with molecular weights <60,000 were ca. 1 per cent of that of the reference glycoproteins. A ratio of 1:1: 1 for mole per cent of sialic acid, per cent molecular weight, and weight per cent activity, was approached by the following inhibitors of B/Md virus: BSM, NN glycoprotein, tryptophan-poor glycoprotein, a,-acid glycoprotein, and the blood-group MM subunit. For Ty-M globulin, a2-macroglobulin, y-A globulin, coeruloplasmin, a1-antitrypsin and Zn-a2-glycoprotein a ratio of molecular weight to activity of 1: 1 was calculated, and that of sialic acid to activity was Ca 0.3. The activity of the remaining nine glycoproteins in Table 1 was much higher than would be the case if a 1: 1 ratio of activity to sialic acid or activity to molecular size existed. Therefore, on the basis of mole per cent sialic acid and per cent molecular weight these nine compounds had a higher activity than reference substance Ca 979.
Toward B/Md virus the ratios of activity to moles of sialic acid and molecular weight, when expressed as per cent of Ca 979, were largest for haptoglobin and Lea substance; with sialic acid as the denominator these ratios were 81 and 65 respectively and with the molecular weight as the denominator they were 35 and 101. These ratios exceeded those of the most active compound, the urinary glycoprotein, manyfold (8 and 10). Such calculations on the other glycoproteins showed that with the B/Md virus the most active compounds relative to their size and sialic acid content were those with molecular weights between 45,000 and 500,000.
Transferrin (molecular weight 90,000, sialic acid 1.5%) and a2-HS-glycoprotein (molecular weight 49,000, sialic acid 4.1%) did not inhibit either virus. Beta2-glycoprotein III (molecular weight 35,000, sialic acid 5.5%) showed no activity for one sample (#167) and traces for two others (#1, #3); these low activities are likely due to contaminants. The homopolymer colominic acid (molecular weight 3,000-4,000) which has no terminal repeating units"5 23 was inactive, even after opening of the internal ester bonds by alkali.
Discussion.-The virus-inhibiting activity of sialoglycoproteins as measured with two influenza virus strains was shown to depend on both molecular size and sialic acid content of the glycoproteins. The inhibiting activity of the glycoproteins toward the PR8 strain of Type A influenza virus increased in proportion to their sialic acid content and molecular size. On the other hand, with the Maryland strain of the Type B influenza virus the relatively highest inhibition was given by glycoproteins with a molecular size of 45,000-500,000. This, VOL. 64, 1969 together with the generally higher potency of all inhibitors toward the B/Md virus, indicates that on the surface of the B/Md virus either fewer combining sites need to be neutralized to prevent red cell agglutination, or smaller, terminal, repeating three-dimensional units on the inhibitory glycoproteins that carry the determinant structures may fulfill the requirements of complementary fit between B/Md virus and inhibitors. Such smaller structures might be expected to occur more frequently, and this in turn would explain why so many more glycoproteins are active with the B/Md virus than with the A/PR8 virus. Lack of properly spaced repeating units or their inaccessibility would account for the inactivity of some sialoglycoproteins.
The inhibitors have indeed been shown to possess repeating subunits terminating in sialic acid.3 11 Thus, over the surface of the OSM molecule (molecular wt. of 1 X 106) 800 sialyl-ca-N-acetyl-galactosaminoyl residues are distributed. 3 The activity of an inhibitor is probably dependent on the number of sialic acid subunits which can simultaneously contact complementary points on the virus surface. It is pertinent therefore that the envelope of myxoviruses is composed of identical repeating subunits; these, from center to center, are approximately 70 A apart. 24 We have calculated that on the OSM molecule sialyl residues can occur at points ca. 70 A apart. The 800 sialyl-a-N-acetyl-galactosaminoyl units are linked 0-glycosidically to seryl and threonyl residues, which amount to about 1,300 per molecule (cf. ref. 25 ). Thus, a sialyl-a-N-acetyl-galactosaminoyl residue is bound to approximately three of every five hydroxy amino acid residues. If an even distribution of the amino acids of the OSM molecule is assumed (for which no structural proof exists), then the distance between two hydroxy amino acids on a fully stretched peptide chain (OSM seems to be a random coil3) amounts to 14.54 A, and the distance between 5 such "identity periods" corresponds to that between 2 repeating subunits on the myxovirus surface. However, since two sialic acids are in excess for each sialic acid required to give a 1:1 correspondence between viral subunit and sialic acids some cluster formation of the hydroxy amino acids and thier substituents would also be permissible. This calculation of a 3: 1 excess of sialic acid over that needed for combination with the virus agrees with the experimental observation of a threefold excess of sialic acid over the observed activity of the OSM of minimal molecular size (Table 2) . A five-fold surplus of sialic acid exists when the mean molecular size of this glycoprotein is taken instead.
Comparison of the peptide backbones of the various glycoproteins indicated no direct relation to activity, nor was there an obvious difference in the distribution pattern of amino acids between active and inactive compounds.
A correlation similar to that found for glycoproteins inhibiting the A/PR8 virus exists for the human erythrocyte blood-group M and N antigens, of which we have obtained fractions ranging in molecular size from 3.0 X 104 to 1.2 X 107, when their blood-group activity is determined with human sera."-"3 It is tempting to speculate that, because of their high activities, the MN blood-group antigens and the T & H urinary glycoprotein are the myxovirus receptors in man, especially in view of their reported occurrence and origin in epithelial
